
Latest headlines
Eli Lilly News
The latest Eli Lilly (LLY) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these LLY headlines next to the live Eli Lilly Fear and Greed Index.
Latest Eli Lilly Headlines60

Eli Lilly Leads 5 Stocks Near Buy Points As The Market Rally Rotates
investors.com · Jun 27, 2026

Is Eli Lilly Stock an Undervalued Healthcare Stock to Buy?
fool.com · Jun 26, 2026

Why Eli Lilly Stock Jumped to a New All-Time High Today
fool.com · Jun 26, 2026

Lilly, J&J and AbbVie Hit New Highs
gurufocus.com · Jun 26, 2026

Eli Lilly shares rise after EU panel backs expanded use of Jaypirca
proactiveinvestors.com · Jun 26, 2026

Eli Lilly (LLY) is a Top-Ranked Momentum Stock: Should You Buy?
zacks.com · Jun 26, 2026

Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
gurufocus.com · Jun 26, 2026

Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
prnewswire.com · Jun 26, 2026

Eli Lilly shares rise after EU panel backs expanded use of Jaypirca
proactiveinvestors.com · Jun 26, 2026

What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management
prnewswire.com · Jun 25, 2026

Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
prnewswire.com · Jun 24, 2026

Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly
reuters.com · Jun 23, 2026

Trump visits Mack Trucks plant in battleground Pennsylvania district to tout economic agenda as midterms loom
foxbusiness.com · Jun 23, 2026

Biotech's Silent Resurgence (5-Year Base Breakout)
zacks.com · Jun 23, 2026

How Eli Lilly Became a $1 Trillion Company
youtube.com · Jun 23, 2026

Eli Lilly says Trump pricing policy will affect obesity drug launches in Europe
reuters.com · Jun 23, 2026

Fund manager names 3 non-AI stocks to own as Intel, AMD sink amid broader tech rout
invezz.com · Jun 23, 2026

Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock
zacks.com · Jun 23, 2026

3 Monster Stocks to Hold for the Next 10 Years
fool.com · Jun 23, 2026

Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk
fool.com · Jun 22, 2026

Eli Lilly vs Pfizer: One Owns the Obesity Market Today, The Other Paid to Compete Tomorrow
247wallst.com · Jun 22, 2026

Lilly declares third-quarter 2026 dividend
gurufocus.com · Jun 22, 2026

Lilly declares third-quarter 2026 dividend
prnewswire.com · Jun 22, 2026

13 Stocks Are Members of the $1 Trillion Club. Here's the Best Pick to Buy Right Now.
fool.com · Jun 22, 2026

Lilly's 7 Acquisitions in 3 Months: Which Will Be the Biggest Game-Changer for the Pharma Giant?
fool.com · Jun 20, 2026

3 Penny Stocks Under $5 Backed by Real Revenue Growth
marketbeat.com · Jun 20, 2026

3 Reasons to Buy Eli Lilly Stock
fool.com · Jun 20, 2026

Vertex Has a Head Start in Non-Opioid Pain. Eli Lilly Just Spent Billions to Catch Up.
fool.com · Jun 20, 2026

Prediction: Eli Lilly Will Trade at $1,200 on This Date
247wallst.com · Jun 19, 2026

Novo Nordisk Stock Rally as Owner Unveils $69 Million Obesity Research Push
gurufocus.com · Jun 19, 2026

Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know
zacks.com · Jun 18, 2026

Can Pfizer Take Share From Lilly & Novo Nordisk in the Obesity Space?
zacks.com · Jun 18, 2026

3 Stocks Doing the Heavy Lifting in Healthcare's Rebound
marketbeat.com · Jun 18, 2026

Eli Lilly Takes Another Stab at the Market for Painkillers. This Attempt Might Work.
barrons.com · Jun 16, 2026

Eli Lilly vs. Novo Nordisk: Better Obesity Drug Stock?
fool.com · Jun 16, 2026

Health Care ETFs: XLV Delivers Low Fees and Solid Returns
fool.com · Jun 16, 2026

Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
gurufocus.com · Jun 14, 2026

Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
prnewswire.com · Jun 14, 2026

Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting
gurufocus.com · Jun 13, 2026

Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting
prnewswire.com · Jun 13, 2026

Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know
zacks.com · Jun 12, 2026

Eli Lilly Stock Hits Buy Zone As Earnings Soar 156%. Funds Are Loading Up.
investors.com · Jun 12, 2026

Here's Why Eli Lilly (LLY) is a Strong Growth Stock
zacks.com · Jun 12, 2026

Forget Eli Lilly and Company: As June Volatility Rocks High-Flyers, This Stock Is a No-Brainer Buy
247wallst.com · Jun 12, 2026

American Express, Live Nation And A Health Care Stock: CNBC's 'Final Trades'
benzinga.com · Jun 12, 2026

Eli Lilly vs Novo Nordisk: The Battle for Obesity Drug Supremacy
247wallst.com · Jun 11, 2026

Pharma and Biotech M&A Boom Accelerates as Companies Expand Pipelines
zacks.com · Jun 11, 2026

MU, GOOGL, LLY & Other Stocks Andrew Arons is Watching This Summer
youtube.com · Jun 11, 2026

An AI Price War Is About to Break Out. You Won’t Believe Who Will Profit Most
247wallst.com · Jun 11, 2026

Healthcare ETFs: From Broad Exposure to Big Breakthroughs
etftrends.com · Jun 11, 2026

I Would Rebuild My Portfolio With Just These 3 Stocks If I Lost Everything Tomorrow
247wallst.com · Jun 10, 2026

Eli Lilly Wins FDA Nod for Extended Ebglyss Dosing in Eczema Care
zacks.com · Jun 10, 2026

Focus: Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon
reuters.com · Jun 10, 2026

Eli Lilly and Company (LLY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
seekingalpha.com · Jun 9, 2026

FDA approves Lilly's EBGLYSS® (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis
prnewswire.com · Jun 9, 2026

As Tech Stocks Slide, The Healthcare Sector Shines. Why Some Experts Say They Like This Defensive Play
investopedia.com · Jun 9, 2026

Deja Vu? AI Overspending Fears Renew
zacks.com · Jun 9, 2026

Is It Too Late To Buy The Rally In Eli Lilly Stock?
forbes.com · Jun 9, 2026

Prediction: Eli Lilly Will Trade at This Price in a Year
247wallst.com · Jun 9, 2026

Lilly Makes a New Alzheimer's Pipeline Move
gurufocus.com · Jun 9, 2026
Why Is Eli Lilly Up or Down Today?
When Eli Lilly (LLY) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a LLY move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Eli Lilly is up or down today.
How Eli Lilly News Affects the Price
News does not move the Eli Lilly (LLY) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Eli Lilly Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Eli Lilly trading volume. That is the chain to watch: headline, sentiment, volume, then the LLY price.
Trade the Eli Lilly News With Sentiment
Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Eli Lilly trading volume spike on a big story, check the Eli Lilly price history for context, follow the live LLY price, see the Eli Lilly price prediction, and read the Eli Lilly Fear and Greed Index for mood.
How do you feel about Eli Lilly?
1DFrequently asked questions
Why is Eli Lilly up or down today?
What is the latest Eli Lilly news?
Where does Eli Lilly news come from?
How often is Eli Lilly news updated?
How does Eli Lilly news relate to its Fear and Greed Index?
Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and more than 100 individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.